SNYR (Synergy CHC Corp) Yalpi foyda marjasi

Synergy CHC (SNYR) korporativ emblemasi va logotipi

Onlayn raqobat tufayli savdo o'sishining sekinlashishi Synergy CHC Corp (SNYR) ning pul oqimini zaiflashtirmoqda. Val gross margin ko'rsatkichi samaradorlikning tiklanishidagi joriy tendentsiyani aks ettiradi, bunda 65.40 ushbu baholash parametrini tavsiflaydi. Marjaning barqarorligi omborlar zanjirining avtomatlashtirilishi bilan ta'minlanmoqda, zaxiralarni boshqarishda dasturiy algoritmlarning joriy etilishi va markazlarning robotlashtirilishi esa xodimlar xarajatlarini minimallashtiradi.

SNYR (Synergy CHC Corp.) Yalpi marja tarixi 24.10.2024dan 03.10.2026gacha

Synergy CHC Corporation (SNYR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Fundamental baholash:SNYR, Synergy CHC Corp
Synergy CHC Corp. brend mahsuloti

Synergy CHC Corp (SNYR) o'zining diversifikatsiyalashgan brendlar portfeli va barqaror chakana savdo pozitsiyalari orqali FDA ning qat'iy tartibga soluvchi muhitida raqobatni samarali jilovlaydi. 65.40 miqdorida qayd etilgan yalpi foyda marjasi taqsimotini tahlil qilish orqali investor bevosita ishlab chiqarish xarajatlaridan tozalangan daromad ulushini ko'rishi mumkin, bu esa xarajatlarning g'ayritabiiy keskin oshishini zudlik bilan aniqlash va biznesning foyda keltirish bo'yicha fundamental qobiliyatini real vaqt rejimida baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja